Drug intelligence / Profile preview

Bassia scoparia pollen

Development stage
Unknown
Lead developer
Allermed Laboratories
Modality
Sublingual Immunotherapy → Allergy Immunotherapy → Therapeutic Vaccines → Vaccines & Immunotherapeutics, Subcutaneous Immunotherapy → Allergy Immunotherapy → Therapeutic Vaccines → Vaccines & Immunotherapeutics
Administration
Percutaneous, Intradermal, Epicutaneous
01

Overview

Bassia scoparia pollen is an allergenic extract derived from the pollen of the *Bassia scoparia* plant (formerly known as *Kochia scoparia*), commonly referred to as firebush or Mexican fireweed. This biologic product is primarily utilized as a diagnostic reagent in skin testing (percutaneous or intradermal) to confirm sensitization in patients suspected of having Type I hypersensitivity to this weed pollen. The extract works by cross-linking allergen-specific IgE antibodies bound to the surface of mast cells and basophils, triggering the release of inflammatory mediators like histamine, which results in a characteristic wheal-and-flare reaction. In addition to its diagnostic role, the extract is used in allergen immunotherapy (AIT) to desensitize patients and reduce symptoms of allergic rhinitis and asthma. It is manufactured by companies such as Allermed Laboratories, Greer Laboratories, and ALK-Abelló.

Other names
Kochia scoparia pollenfirebush pollenMexican fireweed pollenKochia pollen
02

Targets

IgE (Immunoglobulin E)

Beyond the preview

Go deeper on Bassia scoparia pollen.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bassia scoparia pollen.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call